(Q43238313)

English

Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension

scientific article published on 20 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Takayoshi Tsutamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Keizo Nishiyama

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Masayuki Yamaji

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Chiho Kawahara

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Masanori Fujii

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Takashi Yamamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Minoru Horie

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

20 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Hypertension Research

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

118-122

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

21 January 2018

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

21 January 2018

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

21 January 2018

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

21 January 2018

Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Eprosartan Versus Enalapril in Hypertensive Patients on the Renin-Angiotensin-Aldosterone System and Safety Parameters: Results from a 26-Week, Double-blind, Multicentre Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme 2 is an essential regulator of heart function

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

New angiotensins

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular hypertrophy and clinical outcomes in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.192

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2009.192

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43238313&oldid=2205896603"